Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Francois Xavier Babin"'
Autor:
Nay Thiha, Pa Pa Soe, Francois Xavier Babin, Louis Delerome, Hla Hla Win, Philippe Clevenbergh
Publikováno v:
International Journal Of Community Medicine And Public Health. 9:3404
Background: The aim of the study was to provide evidence-based information on the difference in the general health of physically active and inactive people considering their physical and mental health and quality of life.Methods: This study report wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bed6525ba91bee190289150a40ba893c
https://doi.org/10.18203/2394-6040.ijcmph20222200
https://doi.org/10.18203/2394-6040.ijcmph20222200
Autor:
Fetra Angelot Rakotomalala, Julie Bouillin, Santatriniaina Dauphin Randriarimanana, Guillaume Thaurignac, Luca Maharavo, Mihaja Raberahona, Lucien Razafindrakoto, Jasmina Rasoanarivo, Mala Rakoto-Andrianarivelo, Danielle Aurore Doll Rakoto, François Xavier Babin, Tahinamandranto Rasamoelina, Eric Delaporte, Luc Hervé Samison, Martine Peeters, Eric Nerrienet, Ahidjo Ayouba
Publikováno v:
Viruses, Vol 15, Iss 11, p 2258 (2023)
To estimate the prevalence of IgG antibodies against six arboviruses in people living with HIV-1 (PLWHIV) in Madagascar, we tested samples collected between January 2018 and June 2021. We used a Luminex-based serological assay to detect IgG antibodie
Externí odkaz:
https://doaj.org/article/67e1407210b242cbb42a1b18f5647e2e
Autor:
Nay Thiha, Palanivel Chinnakali, Anthony D Harries, Myint Shwe, Thanumalaya Perumal Balathandan, Sai Thein Than Tun, Mrinalini Das, Htay Htay Tin, Yi Yi, François Xavier Babin, Thi Thi Lwin, Philippe Albert Clevenbergh
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0160616 (2016)
WHO recommends that stavudine is phased out of antiretroviral therapy (ART) programmes and replaced with tenofovir (TDF) for first-line treatment. In this context, the Integrated HIV Care Program, Myanmar, evaluated patients for ART failure using HIV
Externí odkaz:
https://doaj.org/article/29dea22344c048da94211222f3d01cb5
Autor:
Phimpha Paboriboune, Thomas Vial, François Chassagne, Philavanh Sitbounlang, Sengaloun Soundala, Stéphane Bertani, Davone Sengmanothong, Francois-Xavier Babin, Nicolas Steenkeste, Paul Dény, Pascal Pineau, Eric Deharo
Publikováno v:
International Journal of Hepatology, Vol 2018 (2018)
Objective. Lao PDR is one of the most highly endemic countries for hepatitis B in Asia and the second country for liver cancer incidence. Therefore, the follow-up of infected individuals through predictive serological markers is of utmost importance
Externí odkaz:
https://doaj.org/article/a54e6939c5e743a7800e922823086da9